and Bornee (1921) respectively, but there appears to be only one published case (Shorvon, 1946) in which the gout supervened upon myeloid leukamia and in which the patient definitely had no family history of gout. The patient described in this text has no known family history of gout and he presents histologically proven gouty tophi which have appeared since the onset and treatment of myeloid leukaemia. As in Shorvon's (1946) case the gout made its first appearance after x-ray. therapy had commenced.
No explanation is advanced why gouty deposits occur in some cases of myeloid leukaemia and not in others, but it should be noted that in this present case the blood uric acid level was extremely high on at least one occasion. Minkowski and Schmidt believed that gout and leukaemia appeared together only by coincidence, and Reifenstein (1945) regarded the presence of palpable tophi, on a single toe of either foot, in a case of subleukaemic myelosis likewise a coincidental feature. Brunner (1932) considered that cases of leukaemia showing gout did so because they also exhibited the special mesenchymal diathesis which he believed to be one of the essential factors governing gout. The number of cases of leukaemia associated with gout reported as having a family history of the latter rather supports Brunner's view despite the absence of such a history in the present case or in that reported by Shorvon (1946) .
The present case is also of interest in that he is well some ten years after the onset of splenomegaly when a diagnosis of chronic myeloid leukaemia was made. It is stated by Wintrobe (1942) 
